brimindinvest.com / compare / mod-vs-aph-connectorLIVE
MODV
ModivCare Inc. · Healthcare - Managed Care / Non-Emergency Medical Transportation
$0.43
N/A this month
VERSUS
COMPARE
APH
Amphenol Corporation · Technology - Electronic Components & Connectors
$158.22
+10.18% this month
Scoreboard verdict
Across AI score, momentum, valuation, upside, operating margin
MODV
0
APH
1
APH LEADS 1/5
Comparison scoreboard
APH LEADS 1/5
AI Score
MODV 21.9
APH 67.5
1Y Return
MODV N/A
APH +60.55%
Fwd P/E
MODV N/A
APH 28.74
Target Up.
MODV N/A
APH +11.79%
Op. Margin
MODV N/A
APH 27.30%
Metrics last refreshed: 7/9/2026
Quick take

MODV vs APH Stock Comparison: AI Score, Valuation, Performance and Upside

MODV (ModivCare) and APH (Amphenol) are unrelated by industry — ModivCare is a Medicaid managed care company in non-emergency medical transportation with an SDOH mission, while Amphenol is a global electronic connector manufacturing powerhouse benefiting from AI infrastructure spending. MODV is a leveraged healthcare services play on Medicaid transportation management; APH is a high-quality compounder in electronic components with secular growth from data centers, EVs, and military.

MODV vs APH is Medicaid NEMT managed care with social determinants of health policy tailwinds and high leverage (ModivCare's dominant position managing 90M+ medical trips for Medicaid members, medical cost ratio risk, and debt burden from acquisition growth) versus diversified global connector manufacturer benefiting from AI infrastructure and defense spending (Amphenol's decentralized 70+ business unit model, high-speed data center connector growth, and prolific acquisition compounder strategy) — leveraged healthcare services versus compounding industrial technology leader.

Live analysis · updated 7/9/2026

APH holds the edge across 1 of 5 key metrics in this comparison.

Normalized 1Y performance
MODV
APH
Not enough data to chart yet.
Recent returns
MODV
APH
Analyst price targets & sentiment
MODV
Price target data unavailable
N/A
APH · 17 analysts
STRONG BUYHOLDSTRONG SELL
Buy (1.9/5.0)
Price target range
analyst low$70.00
analyst mean$184.00
current price$158.22
+11.8% upside to analyst mean
Who should consider this stock?
MODV may suit investors who:
  • Believe ModivCare's dominant NEMT position and scale advantages make it difficult for Medicaid plans to replace, creating durable contract renewals
  • See SDOH policy momentum driving Medicaid plan investment in transportation as preventive care, expanding ModivCare's addressable market
  • Are willing to accept the NEMT medical cost ratio risk and high leverage in exchange for a below-market valuation on the dominant managed transportation services platform
APH may suit investors who:
  • Want exposure to AI data center infrastructure spending through a high-quality connector manufacturer with decades of compounding track record
  • Value Amphenol's decentralized operating model as a sustainable competitive advantage creating faster innovation and higher management accountability than centralized competitors
  • Seek a consistent earnings compounder growing through economic cycles via organic growth, operating leverage, and disciplined acquisitions
Performance & AI score
MetricMODVAPH
AI score21.967.5
AI rank#4488#52
Latest close$0.43$158.22
1M returnN/A+10.18%
6M returnN/A+11.91%
1Y returnN/A+60.55%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

PeriodMODVAPH
1Y agoN/A$16.24K (+62.4%)
started 2025-07-08
5Y agoN/A$48.45K (+384.5%)
started 2021-07-09
10Y agoN/A$130.64K (+1206.4%)
started 2016-07-11

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
MetricMODVAPH
Market capN/A$202.48B
Trailing P/EN/A47.43
Forward P/EN/A28.74
Price/Sales0.006.73
EV/RevenueN/A8.37
Analyst targetN/A$184.00
Target upsideN/A+11.79%
Growth, profitability & risk
MetricMODVAPH
Revenue growthN/A58.40%
Earnings growthN/A24.10%
EPS growthN/A+24.10%
FCF marginN/A+13.76%
Operating marginN/A27.30%
Profit marginN/A17.24%
ROIC proxyN/A36.83%
Return on equityN/A36.83%
Dividend yieldN/A0.61%
Beta-1.711.24
Debt/equityN/A133.05
Current ratioN/A1.71
Quick ratioN/A1.17
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
MODV max drawdownN/A
APH max drawdown28.33%
MODV max wkly dropN/A
APH max wkly drop14.67%
5Y risk snapshot
MODV max drawdownN/A
APH max drawdown28.73%
MODV max wkly dropN/A
APH max wkly drop14.67%
10Y risk snapshot
MODV max drawdownN/A
APH max drawdown37.56%
MODV max wkly dropN/A
APH max wkly drop20.93%
Performance metrics by period
PeriodMetricMODVAPH
1YGrowthN/A+62.43%
CAGRN/A+62.54%
Sharpe ratioN/A1.25
Max drawdownN/A28.33%
Max daily dropN/A12.20%
Max wkly dropN/A14.67%
5YGrowthN/A+366.84%
CAGRN/A+36.11%
Sharpe ratioN/A1.01
Max drawdownN/A28.73%
Max daily dropN/A12.57%
Max wkly dropN/A14.67%
10YGrowthN/A+1096.04%
CAGRN/A+28.19%
Sharpe ratioN/A0.87
Max drawdownN/A37.56%
Max daily dropN/A13.88%
Max wkly dropN/A20.93%
Business comparison
CategoryMODVAPH
CompanyModivCare Inc.Amphenol Corporation
SectorHealthcare - Managed Care / Non-Emergency Medical TransportationTechnology
IndustryN/AElectronic Components
Core businessModivCare is a tech-enabled managed care company focused on non-medical services addressing social determinants of health for Medicaid and Medicare Advantage populations. Three segments: Non-Emergency Medical Transportation (NEMT) — manages transportation benefits for Medicaid members connecting patients with rides to medical appointments through a nationwide driver network (approximately 90M+ NEMT trips annually for 30M+ members); Remote Patient Monitoring (RPM) — provides devices and software for monitoring chronic disease patients remotely; Personal Care Services — homecare worker staffing for Medicaid members needing assistance with daily activities. Medicaid and Medicare Advantage plans pay ModivCare fixed per-member-per-month (PMPM) fees to manage transportation benefits.Amphenol is one of the world's largest manufacturers of electrical, electronic, and fiber optic connectors and interconnect systems. Applications span military and aerospace (ruggedized connectors for missiles, aircraft, naval systems), automotive (EV charging connectors, vehicle body and engine management connectors), data communications (high-speed connectors for data center servers, networking switches, AI accelerator modules), industrial (factory automation, sensors, energy infrastructure), mobile devices, and broadband. Amphenol is a global manufacturer with a highly decentralized structure running over 70 independent business units.
Investor focusInvestors track ModivCare's medical cost ratio (actual transportation spend versus PMPM fees received), NEMT contract wins and renewals, RPM subscriber growth, and free cash flow generation.Investors track Amphenol's organic revenue growth by segment (especially IT datacom and military), operating margins, acquisition pipeline, and exposure to AI infrastructure spending (high-speed connectors for AI data centers).
MODV strengths
  • Dominant managed NEMT platform with scale advantages — ModivCare is the largest U.S. NEMT managed care company; managing 90M+ trips annually provides transportation cost data, driver network density, and Medicaid plan relationships competitors cannot replicate
  • Social determinants of health (SDOH) policy tailwind — healthcare policy increasingly emphasizes addressing non-clinical needs (transportation, housing) affecting outcomes; NEMT prevents missed appointments that worsen chronic disease and increase costly ER visits
  • RPM and personal care diversification reduces NEMT concentration — adding remote monitoring and personal care services creates multiple revenue streams within the same Medicaid population ModivCare already serves
APH strengths
  • Decentralized business unit model drives superior management accountability and fast decision-making — 70+ independently managed P&L centers operate like entrepreneurial small companies with Amphenol resources; this model outperforms centralized connector manufacturers in innovation speed
  • Diversification across military, automotive, datacom, industrial, and mobile creates resilience — segment diversification smooths the revenue cycle versus single-segment makers
  • AI infrastructure build-out is a powerful growth driver — AI data centers require enormous quantities of high-speed connectors for GPU-to-GPU interconnects, PCIe backplanes, power delivery, and networking; Amphenol's high-speed data center connectors are growing substantially faster than the overall business
Risks to watch — MODV
  • NEMT medical cost ratio risk — if actual trip costs exceed contracted PMPM fees, ModivCare absorbs the loss; fuel price spikes, driver shortages, or higher trip volumes compress margins
  • Medicaid redetermination cycles create membership volatility — when members lose Medicaid eligibility, ModivCare loses PMPM revenue; large membership fluctuations create revenue uncertainty
  • High debt load from acquisitions constrains flexibility — ModivCare executed several acquisitions building scale; resulting debt requires FCF allocation to debt reduction, limiting strategic investments
Risks to watch — APH
  • Automotive connector exposure creates cyclical risk — auto production volumes are cyclical; EV transition creates short-term uncertainty as OEMs navigate model transitions
  • Competition from TE Connectivity, Molex, and Samtec in key markets — share is maintained through product innovation and acquisitions but faces motivated competitors
  • Acquisition pace creates integration complexity — Amphenol acquires 5-15 connector companies per year; managing quality and culture across dozens of simultaneous acquisitions requires consistent execution
Frequently asked questions
NEMT covers rides to and from medical appointments that are medically necessary but not emergencies — a dialysis patient getting three rides per week to a dialysis center, a pregnant woman attending prenatal appointments, a diabetic patient seeing their endocrinologist. Federal requirement: the federal government has required states to provide NEMT benefits to Medicaid recipients since 1966 (Social Security Act); missed appointments lead to disease progression, hospitalizations, and higher long-term Medicaid costs. ModivCare's role: rather than Medicaid plans managing driver networks across 50 states, plans hire ModivCare as a managed NEMT company; ModivCare takes a per-member-per-month fee and manages dispatch, driver network, trip verification, and fraud prevention. Market: the NEMT market is approximately $6-7B annually; ModivCare manages roughly 40-50% of all managed NEMT in the U.S.
AI Prediction SignalNext 5 trading days
Members only
MODV
+2.8%BUY
APH
+1.1%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

Related comparisons
More comparisons
Browse all 1,000 comparisons →